Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Certain drugs that block specific enzymes can help treat prostate diseases.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Menopause affects hair and skin; more research needed for treatment.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

The normal human prostate does not significantly affect blood DHT levels.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.